Bupivacaine
CAS 2180-92-9 5 FDA-DMF suppliersSmall Molecule
Overview
Bupivacaine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1098).
Patent & exclusivity (US)
Per the FDA Orange Book (51 approved US products), the latest listed US patent on Bupivacaine expires 1 Jul 2044 and exclusivity 9 Nov 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
- Canonical SMILES
- CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
- InChIKey
- LEBVLXFERQHONN-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.